OM:EQT is expanding into the secondaries market through a partnership with Coller Capital. The company and Coller Capital plan to work together on secondaries-focused investment solutions. The EQT ...

Regeneron Pharmaceuticals Inc (REGN) reports a 3% revenue increase, driven by robust sales of Dupixent and strategic pipeline developments, despite competitive pressures and rising R&D expenses.

If we’re not explicitly designing for inclusion and accessibility, then we’re designing for more exclusion. As designers, it’s our shared responsibility to build a more inclusive, ethical, and ...

Ryan Eichler holds a B.S.B.A with a concentration in Finance from Boston University. He has held positions in, and has deep experience with, expense auditing, personal finance, real estate, as well as ...